CompaniesByCap
AVTX
Avalo Therapeutics Inc. (AVTX)
NASDAQ · Healthcare

Avalo Therapeutics Inc. Income Statement 2015–2025

Income StatementBalance SheetCash Flow
Dec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016Dec 2015
Revenues
Revenue59,000441,0001.9M18.1M5.4M6.7M6.8M7.0M27.8M1.2M0
Gross Profit640,00014.6M3.9M6.4M7.3M3.8M27.2M1.2M0
Profitability
Operating Income-72.9M-68.5M-27.4M-37.4M-82.1M-72.8M-16.1M-35.4M13.9M-16.1M-11.0M
EBITDA-72.6M-68.3M-27.2M-37.3M-80.5M-71.0M-12.3M-30.8M14.3M-16.1M-11.0M
Net Income-78.3M-35.1M-31.5M-41.7M-84.4M-63.5M-16.1M-40.1M11.9M-16.5M-10.5M
Per Share Data
EPS (diluted)
Shares Outstanding (dil.)13M7M0M0M9M75M44M35M19M9M2M

Avalo Therapeutics Inc. Income Statement — FAQ

Avalo Therapeutics Inc. (AVTX) income statement over the last 11 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see AVTX's income statement history?

The chart and table above show Avalo Therapeutics Inc.'s income statement by year and by quarter, including the growth rate.